Innovative digital health company specialised in psychological diagnostics

This opportunity concerns a young innovative company specialised in digital health and psychological diagnostics. Born from university research, it offers a certified software solution that revolutionises the assessment of mental disorders. The platform enables comprehensive symptom identification, visualises them as structured mapping and generates diagnostic suggestions to support professionals towards rapid and targeted therapeutic care. With over six years of fundamental research and an active commercial presence since 2019, this company offers the first and only clinically validated psychological diagnostic tool available in Europe. Its technology benefits from CE certification, guaranteeing compliance with the strictest medical standards. The client portfolio includes major sector players, notably leading insurance companies as well as numerous psychiatric clinics and private practices in Switzerland and Germany. The management team possesses in-depth expertise in digital health, medical regulation and commercial development. It relies on a solid professional network in the industry and drives dynamic and continuous growth. This company actively contributes to improving access to psychological care through digital means and to directing affected individuals more quickly towards appropriate support. This is an equity participation opportunity as part of a capital increase. The company is seeking strategic investors ready to support its expansion in German-speaking markets and beyond. This operation will accelerate product development, strengthen commercial presence and consolidate technological leadership in a sector undergoing transformation. If you wish to participate in a meaningful entrepreneurial venture, combining scientific innovation and social impact in the field of mental health, this opportunity deserves your attention.